Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.

Zito JM, Safer DJ, Zuckerman IH, Gardner JF, Soeken K.

Psychiatr Serv. 2005 Feb;56(2):157-63.

PMID:
15703342
2.

Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.

Zito JM, Burcu M, Ibe A, Safer DJ, Magder LS.

Psychiatr Serv. 2013 Mar 1;64(3):223-9. doi: 10.1176/appi.ps.201200081.

PMID:
23242390
3.
4.

Multiple psychotropic medication use for youths: a two-state comparison.

dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL.

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):68-77.

PMID:
15741788
5.

Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland.

Zito JM, Safer DJ, dosReis S, Riddle MA.

J Am Acad Child Adolesc Psychiatry. 1998 Feb;37(2):179-84.

PMID:
9473914
6.

Mental health services for youths in foster care and disabled youths.

dosReis S, Zito JM, Safer DJ, Soeken KL.

Am J Public Health. 2001 Jul;91(7):1094-9.

7.

Anticonvulsant treatment for psychiatric and seizure indications among youths.

Zito JM, Safer DJ, Gardner JF, Soeken K, Ryu J.

Psychiatr Serv. 2006 May;57(5):681-5.

PMID:
16675763
8.

Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008.

Fontanella CA, Warner LA, Phillips GS, Bridge JA, Campo JV.

Psychiatr Serv. 2014 Nov 1;65(11):1332-40. doi: 10.1176/appi.ps.201300410. Epub 2014 Oct 31.

9.

The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?

Shone LP, Dick AW, Brach C, Kimminau KS, LaClair BJ, Shenkman EA, Col JF, Schaffer VA, Mulvihill F, Szilagyi PG, Klein JD, VanLandeghem K, Bronstein J.

Pediatrics. 2003 Dec;112(6 Pt 2):e521.

PMID:
14654674
10.
11.

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.

Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE.

Pediatrics. 2008 Mar;121(3):e441-8. doi: 10.1542/peds.2007-0984.

12.

Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.

dosReis S, Owens PL, Puccia KB, Leaf PJ.

Psychiatr Serv. 2004 Sep;55(9):1041-8.

PMID:
15345765
13.

Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications.

Harris E, Sorbero M, Kogan JN, Schuster J, Stein BD.

Psychiatr Serv. 2012 Apr;63(4):351-6. doi: 10.1176/appi.ps.201100329.

PMID:
22337007
14.

Methylphenidate patterns among Medicaid youths.

Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA.

Psychopharmacol Bull. 1997;33(1):143-7.

PMID:
9133766
15.

Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care.

Martin A, Van Hoof T, Stubbe D, Sherwin T, Scahill L.

Psychiatr Serv. 2003 Jan;54(1):72-7.

PMID:
12509670
16.

Family income and the impact of a children's health insurance program on reported need for health services and unmet health need.

Feinberg E, Swartz K, Zaslavsky A, Gardner J, Walker DK.

Pediatrics. 2002 Feb;109(2):E29.

PMID:
11826239
17.

Psychotropic medication use among Kansas Medicaid youths with disabilities.

Shireman TI, Reichard A, Rigler SK.

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):107-15.

PMID:
15741792
18.

Eligibility and enrollment of adolescents in Medicaid and SCHIP: recent progress, current challenges.

Morreale MC, English A.

J Adolesc Health. 2003 Jun;32(6 Suppl):25-39.

PMID:
12782442
19.

Trends in the prescribing of psychotropic medications to preschoolers.

Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F.

JAMA. 2000 Feb 23;283(8):1025-30.

PMID:
10697062
20.

Psychotropic practice patterns for youth: a 10-year perspective.

Zito JM, Safer DJ, DosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA.

Arch Pediatr Adolesc Med. 2003 Jan;157(1):17-25.

PMID:
12517190

Supplemental Content

Support Center